Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
Revolution Medicines’ $230 Million Shares Offering
Atairos’ $580 Million Take Private of Ocean Outdoor
Davis Polk, Vinge and Ogier advised Atairos in the transaction, while White & Case advised Ocean Outdoor. Atairos announced its $580 million recommended acquisition of the entire...
Medtronic’s Acquisition of Left-Heart Access Business from Acutus
Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. announced the sale of its left-heart access portfolio products to Medtronic, for an upfront payment of...
Xponential Fitness’ Common Stock Offering
Davis Polk advised Xponential Fitness, while Latham & Watkins represented the underwriters in the offering. Xponential Fitness, Inc., the largest global franchisor of boutique fitness brands,...
Credo Technology Group’s $200 Million Initial Public Offering
Davis Polk advised Credo Technology Group Holding Ltd on the IPO while S&C represented the underwriters. Credo announced its $200 million initial public offering of 20,000,000 ordinary...
Revolution Medicines’ $250 Million Shares Offering
Davis Polk advised the sales agent, Cowen, in the offering. Revolution Medicines, Inc. announced it may issue and sell shares of its common stock for up...
TaskUs’ $766.9 Million Follow-on Offering
Davis Polk advised the representatives of the several underwriters in the offering. Simpson Thacher represented TaskUs. TaskUs, Inc. announced the upsized $766.9 million public offering of 12,077,480...
RxSight’s $117.6 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. RxSight, Inc. executed an initial public offering of 7,350,000 shares of common stock at $16.00 per...
Xponential Fitness’ $120 Million Initial Public Offering
Davis Polk advised Xponential Fitness in its IPO, while Latham & Watkins represented the underwriters. Xponential Fitness, Inc. executed its $120 million initial public offering of 10,000,000...
Acutus Medical’s $77 Million Shares Offering
Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. executed its SEC-registered public offering of 5,500,000 shares of common stock for an aggregate price...
NeuroPace’s $102 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
Ultra Clean’s $175 Million Follow-on Offering
Davis Polk advised Ultra Clean Holdings on the deal. Ultra Clean Holdings, Inc. executed its SEC-registered follow-on public offering of 3,181,818 shares of common stock for...